District Courts

Federal district court decisions

District Courts, Utility Patent

Valjakka v. Netflix — Judge Awards $3M Attorney Fees After Finnish Inventor Concealed Foreign Court’s Patent Ownership Ruling

A Northern District of California judge awarded Netflix $3 million in attorney fees after finding that plaintiff Lauri Valjakka and his counsel committed fraud by asserting ownership of U.S. Patent No. 8,495,167 while concealing a Finnish court’s prior determination that Valjakka did not own the patent — rendering the entire suit objectively baseless from its inception.

District Courts, Trade Secret, Federal

Signant Health v. Definium Therapeutics — Delaware Court Dismisses LSD-Drug Trade Secret Suit for Lack of Specificity

A Delaware federal judge dismissed Signant Health’s DTSA trade secret claims against Definium Therapeutics, finding that identifying confidential LSD-trial technology only in broad, categorical terms — without pinpointing the specific information allegedly misappropriated — is insufficient to survive a motion to dismiss.

District Courts, Utility Patent

GlaxoSmithKline v. Pfizer/BioNTech and Moderna — Delaware Court Keeps Prosecution Laches Defense Alive in mRNA Vaccine Patent War

Judge Gregory Williams of the District of Delaware denied GlaxoSmithKline’s motions to dismiss prosecution laches defenses asserted by Pfizer/BioNTech and Moderna, finding the defendants plausibly alleged that GSK unreasonably delayed patent prosecution for over a decade and then broadened mRNA vaccine claims only after its rivals’ COVID vaccine technology became public.

Scroll to Top